- Home
- RCUS vs UWMC Comparison
RCUS vs UWMC Comparison
Compare RCUS & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- UWMC
- Stock Information
- Founded
- RCUS 2015
- UWMC 1986
- Country
- RCUS United States
- UWMC United States
- Employees
- RCUS N/A
- UWMC N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- UWMC Finance: Consumer Services
- Sector
- RCUS Health Care
- UWMC Finance
- Exchange
- RCUS Nasdaq
- UWMC Nasdaq
- Market Cap
- RCUS 1.2B
- UWMC 1.4B
- IPO Year
- RCUS 2018
- UWMC N/A
- Fundamental
- Price
- RCUS $12.03
- UWMC $6.71
- Analyst Decision
- RCUS Buy
- UWMC Hold
- Analyst Count
- RCUS 8
- UWMC 7
- Target Price
- RCUS $20.71
- UWMC $5.54
- AVG Volume (30 Days)
- RCUS 711.9K
- UWMC 8.2M
- Earning Date
- RCUS 11-05-2025
- UWMC 11-06-2025
- Dividend Yield
- RCUS N/A
- UWMC 5.97%
- EPS Growth
- RCUS N/A
- UWMC 112.84
- EPS
- RCUS N/A
- UWMC 0.07
- Revenue
- RCUS $262,000,000.00
- UWMC $2,622,828,000.00
- Revenue This Year
- RCUS N/A
- UWMC $25.96
- Revenue Next Year
- RCUS N/A
- UWMC N/A
- P/E Ratio
- RCUS N/A
- UWMC $101.16
- Revenue Growth
- RCUS 6.07
- UWMC 13.45
- 52 Week Low
- RCUS $6.50
- UWMC $3.80
- 52 Week High
- RCUS $18.98
- UWMC $9.17
- Technical
- Relative Strength Index (RSI)
- RCUS 66.27
- UWMC 70.16
- Support Level
- RCUS $11.30
- UWMC $5.50
- Resistance Level
- RCUS $12.05
- UWMC $6.99
- Average True Range (ATR)
- RCUS 0.58
- UWMC 0.25
- MACD
- RCUS 0.02
- UWMC 0.02
- Stochastic Oscillator
- RCUS 81.30
- UWMC 73.80
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.